Sermorelin Enhances NMJ Stability in U.S. Males with Neuromuscular Disorders
Reading Time: 3 minutes Introduction Neuromuscular disorders (NMDs), encompassing conditions such as amyotrophic lateral sclerosis (ALS), myasthenia gravis (MG), and spinal muscular atrophy (SMA), pose significant challenges to American males, who account for approximately 60% of ALS diagnoses and higher prevalence in hereditary NMDs per CDC data. These disorders disrupt neuromuscular junction (NMJ) function, the critical synapse between motor neurons and skeletal muscle fibers, leading to muscle weakness, fatigue, and progressive disability. Sermorelin, a synthetic analog of growth hormone-releasing hormone (GHRH), has emerged as a promising adjunctive therapy. By stimulating endogenous growth hormone (GH) and insulin-like growth factor-1 (IGF-1) secretion, sermorelin may enhance NMJ...


